⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8947063 | 0.95 | ALDH1A1 (0.46) | — | |
| SCHEMBL8947078 | 0.87 | ALDH1A1 (0.60) | — | |
| SCHEMBL8947125 | 0.83 | L3MBTL1 (0.48) | — | |
| SCHEMBL9568720 | 0.82 | MAPK1 (0.43) | — | |
| SCHEMBL8947316 | 0.82 | ALDH1A1 (0.63) | — | |
| SCHEMBL8947169 | 0.82 | ALDH1A1 (0.49) | — | |
| SCHEMBL8947140 | 0.79 | HSD11B1 (0.59) | — | |
| SCHEMBL8947311 | 0.79 | ALDH1A1 (0.57) | — | |
| SCHEMBL8947149 | 0.79 | ALDH1A1 (0.51) | — | |
| SCHEMBL5966689 | 0.79 | TRPV1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE35281-E | ANTIDIABETIC AGENTS | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1996-06-18 | — | — | US | disclosed |
| EP-0388967-B1 | Aldose reductase inhibitor | WAKAMOTO PHARMA CO LTD (JP) | 1995-06-28 | — | — | EP | disclosed |
| US-5055481-A | Alleviate diabetic complications | WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) | 1991-10-08 | — | — | US | disclosed |
| EP-0388967-A1 | Aldose reductase inhibitor | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1990-09-26 | — | — | EP | disclosed |